SCHEMBL2162435

SCHEMBL2162435

CC1OCc2sc(N)c(C(=O)c3ccco3)c21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.37
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
TDP1 Q9NUW8 2/20 0.37
POLB P06746 1/20 0.37
THRB P10828 1/20 0.37
APEX1 P27695 1/20 0.37
RECQL P46063 1/20 0.37
NPC1 O15118 6/20 0.35
RAB9A P51151 6/20 0.35
TP53 P04637 3/20 0.35
SCN3A Q9NY46 1/20 0.35
MELK Q14680 1/20 0.35
KDM4E B2RXH2 3/20 0.35
HSD17B10 Q99714 2/20 0.35
TSHR P16473 1/20 0.35
MAPT P10636 5/20 0.34
EGFR P00533 1/20 0.34
SRC P12931 1/20 0.34
SMN1; SMN2 Q16637 5/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2162376 0.74 CNR2 (0.45) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL5679977 0.72 MAPT (0.64) ALDH1A1MEN1KMT2ATDP1POLB
SCHEMBL137201 0.72 MAPT (0.60) ALDH1A1MEN1KMT2ATDP1POLB
SCHEMBL2162097 0.72 CNR2 (0.47) ALDH1A1MEN1KMT2APOLBNPC1
SCHEMBL5675302 0.71 ALDH1A1 (0.60) ALDH1A1MEN1KMT2ATDP1POLB
SCHEMBL2162345 0.70 CNR1 (0.38) ALDH1A1MEN1KMT2ARECQLKDM4E
SCHEMBL2162281 0.69 ALDH1A1 (0.54) ALDH1A1MEN1KMT2ATDP1POLB
SCHEMBL20339216 0.69 ALOX15 (0.42) MEN1KMT2ATDP1POLBNPC1
SCHEMBL5676520 0.66 ADORA1 (0.74) ALDH1A1MEN1KMT2APOLBKDM4E
SCHEMBL181841 0.63 ALDH1A1 (0.74) ALDH1A1MEN1KMT2ATDP1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7985768-B2 2-carbonylamino-4,6-dihydrothieno[2,3-c]furans such as ethyl 2-{[2-fluoro-6-(trifluoromethyl)benzoyl]amino}-4-methyl-4,6-dihydrothieno[2,3-c]furan-3-carboxylate; CB2 receptors ligands for immune and inflammatory conditions; pain; neuroprotectants ABBOTT LABORATORIES (US) 2011-07-26 US disclosed
US-20080058308-A1 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS ABBOTT LABORATORIES (US) 2008-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058308-A1 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS CNR1, CNR2, OPRL1 ALDH1A1 1497/4885MEN1 2994/4885KMT2A 2756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.